Literature DB >> 3283385

Treatment of chronic prostatitis: intraprostatic antibiotic injections under echography control.

J F Jiménez-Cruz1, F B Tormo, J G Gómez.   

Abstract

We treated 51 patients diagnosed as having chronic bacterial prostatitis (gram-negative) with 2 ml. intraprostatic amikacin (500 mg.) or tobramycin (100 mg.) weekly for 2 to 4 weeks. Administration was perineal with echographic control and injection was done in the echogenic zone or external gland. In each case the diagnosis was obtained by fractioned microbiological study via the method of Meares and Stamey. This test was repeated 4, 12 and 24 weeks after the end of treatment. Of the patients 25 (49 per cent) were cured microbiologically, 11 (21.5 per cent) were cured after a second cycle of treatment and the remaining 15 (29.4 per cent) failed to respond. The clinical cure rate was 43.1 per cent and 41.1 per cent of the patients were improved. After 6 months 5 patients had relapse and 1 had reinfection. No differences were observed with both antimicrobials. The microbiological cure indexes of 70.5 and 58.8 per cent after 3 and 6 months, respectively, compared favorably with that obtained by oral therapy with antimicrobials that reach effective levels in the prostatic fluid. Transitory post-injection hemospermia was observed in 11 patients. Together with pain during or after injection (8 and 5 patients, respectively), these were the sole adverse effects observed with this therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3283385     DOI: 10.1016/s0022-5347(17)42733-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Fluoroquinolone Antimicrobial Agents in the Treatment of Prostatitis and Recurrent Urinary Tract Infections in Men.

Authors:  F M E Wagenlehner; K G Naber
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

Review 2.  Prostatitis: the role of antibiotic treatment.

Authors:  F M E Wagenlehner; K G Naber
Journal:  World J Urol       Date:  2003-04-10       Impact factor: 4.226

3.  Synergistic activity of tobramycin-netilmicin against Enterococcus faecalis producing 6'-aminoglycoside-acetyltransferase, 2''-aminoglycoside-phosphotransferase enzyme.

Authors:  C Torres; J M Torres; C Tenorio; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

Review 4.  Minimally invasive therapies for prostatitis.

Authors:  Peter Zvara; Jeffrey B Folsom; Mark K Plante
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

Review 5.  New therapies in chronic prostatitis.

Authors:  Nivedita Bhatta Dhar; Daniel A Shoskes
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

Review 6.  Advanced therapy for prostatitis: minimally invasive and invasive therapies.

Authors:  Assaad El-Hakim; Darshan K Shah; Arthur D Smith
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

Review 7.  Treatment response to conventional and novel therapies in chronic prostatitis.

Authors:  Daniel A Shoskes
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

Review 8.  Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men.

Authors:  F M E Wagenlehner; K G Naber
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 2.862

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.